Patents by Inventor Sarah Adler

Sarah Adler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Toxicity assay based on human blastocyst-derived stem cells and progenitor cells
    Patent number: 8153359
    Abstract: An in vitro toxicity assay based on human blastocyst-derived stem cells for the detection of toxicity in the human species is provided, which enables novel detection of in vitro human toxicity for a substance and/or more efficiently detects human toxicity compared to non-human assays. Furthermore, the detection of toxicity for substances is enabled, which is known to display inter-species differences and the toxic effect was not detectable by toxicological tests in mice.
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: April 10, 2012
    Assignee: Cellartis AB
    Inventors: Raimund Strehl, Sarah Adler
  • NOVEL TOXICITY ASSAY BASED ON HUMAN BLASTOCYST-DERIVED STEM CELLS AND PROGENITOR CELLS
    Publication number: 20100047842
    Abstract: An in vitro toxicity assay based on human blastocyst-derived stem cells for the detection of toxicity in the human species is provided, which enables novel detection of in vitro human toxicity for a substance and/or more efficiently detects human toxicity compared to non-human assays. Furthermore, the detection of toxicity for substances is enabled, which is known to display inter-species differences and the toxic effect was not detectable by toxicological tests in mice.
    Type: Application
    Filed: October 2, 2007
    Publication date: February 25, 2010
    Applicant: Cellartis AB
    Inventors: Raimund Strehl, Sarah Adler
  • Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells
    Publication number: 20080132424
    Abstract: The invention relates to an in vitro toxicity assay based on human blastocyst-derived stem cells for the detection of toxicity in the human species, which enables novel detection of in vitro human toxicity for a substance and/or more efficiently detects human toxicity compared to non-human assays. The invention can furthermore enable detection of toxicity for substances, which are known to display inter-species differences and the toxic effect was not detectable by toxicological tests in mice.
    Type: Application
    Filed: October 2, 2007
    Publication date: June 5, 2008
    Inventors: Raimund Strehl, Sarah Adler
  • Display screen with graphical user interface
    Patent number: D869492
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: December 10, 2019
    Assignee: SCRIPPS NETWORKS, LLC
    Inventor: Sarah Adler